Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
Metabolism
; 147: 155663, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37517791
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Obesity, Morbid
/
Diabetes Mellitus, Type 2
/
Bariatric Surgery
/
Non-alcoholic Fatty Liver Disease
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Metabolism
Year:
2023
Document type:
Article
Affiliation country:
Spain
Country of publication:
United States